Since severities of liver disease may influence chemerin/CMKLR1 axis in the liver tissues [32], we believe that investigation on guts may help to get insight the role of chemerin/CMKLRS axis on NAFLD. The gene discussed is RARRES2; the disease is metabolic dysfunction-associated steatotic liver disease.